IFS is believed to be a useful treatment for PTSD. A new study provides the first research-based evidence of its efficacy.

In a first-of-its-kind clinical study, scientists at the University of Texas at Dallas and Baylor University Medical Center have shown that patients with treatment-resistant PTSD were symptom-free up ...

Quitting cannabis may yield greater improvements in PTSD symptoms than continued use in adults with both PTSD and cannabis use disorder, a small study suggests.

Many people have interpreted as a setback the “no” vote by an advisory committee to the Food and Drug Administration on Lykos Therapeutics’ new drug application for MDMA-assisted psychotherapy for ...

Clerkenwell Health, the modern mental health company specializing in matching patients with cutting-edge psychiatry treatments, today announced that it is taking part in Transcend Therapeutics’ Phase ...

A novel, non-hallucinogenic, experimental drug shows statistically significant, rapid, and durable improvement in PTSD symptom severity in a phase 2 trial.

After years of delays, researchers are set to move forward on a landmark clinical trial meant to evaluate the efficacy of smoked medical marijuana in treating post-traumatic stress disorder (PTSD) in ...

EDITOR'S NOTE — This story includes discussion of suicide. If you or someone you know needs help, the national suicide and crisis lifeline in the U.S. is available by calling or texting 988. There is ...

A genetic study involving more than 1.2 million people has pinpointed 95 genetic loci that are associated with risk of developing post-traumatic stress disorder (PTSD), including 80 loci that had not ...

The leadership group for the Texas Biomedical Device Center includes, from left, Dr. Michael Kilgard, Dr. Jane Wigginton, Dr. Seth Hays and Dr. Robert Rennaker. In a first-of-its-kind clinical study, ...